Grant Support

Current

• "IDO Inhibitors for Combinatorial Cancer Therapy", National Institutes of Health (National Cancer Institute, R01 CA109542-04A2), a collaboration with Lankenau Institute of Medical Research, 20011-15.
• “400 MHz NMR Acquisition”, National Science Foundation, Major Research Instrumentation Program (Recovery and Reinvestment, CHE-0958996), 2010-2012.
• “Synthetic tools for new antibiotics”, National Institutes of Health (National Institute of General Medical Sciences, 1-R15-GM087291-01A1), 2010-2012.

Past

• "Sequential Birch reduction-allylation/Cope rearrangement for the enantioselective construction of carbocyclic quaternary stereogenic centers", American Chemical Society, The Petroleum Research Fund (PRF# 43238-AC1), 2005-9
• American Chemical Society PRF 2008 Supplement for Underrepresented Minority Research Fellowship
• "IDO Inhibitors for Combinatorial Cancer Therapy", National Institutes of Health (National Cancer Institute, R01-CA109542), a collaboration with Lankenau Institute of Medical Research, 2005-8.
• "New Tools for the Synthesis of Cyanthiwigin AC and Analogs", Pennsylvania Department of Health, Commonwealth Universal Research Enhancement (CURE) Program, 2006.
• "The Asymmetric Synthesis of alpha-Aminophosphonic Acids", National Institutes of Health (AREA, 1-R15-GM58469-01), 1999-2003.
•  Bristol-Myers Squibb Undergraduate Research Award in Organic Chemistry, 2001, 2002, 2004, 2006, and 2007.
• "Design, Synthesis and Evaluation of a Novel Serine Protease Inhibitor Based on Monocyclic beta-Lactams", National Science Foundation (RUI, CHE-9710479), 1997-2000.

 

Return to Bill Malachowski web page